Cargando…

Insulin Resistance Is Not Increased in Inflammatory Bowel Disease Patients but Is Related to Non-Alcoholic Fatty Liver Disease

Background. Insulin resistance (IR) has been linked to inflammatory states. The aim of this study was to determine whether IR is increased in a cohort of inflammatory bowel disease (IBD) patients with low disease activity. We additionally intended to establish which factors were the determinants of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carrillo-Palau, Marta, Hernández-Camba, Alejandro, Hernández Alvarez-Buylla, Noemi, Ramos, Laura, Alonso-Abreu, Inmaculada, Hernández-Pérez, Anjara, Vela, Milagros, Arranz, Laura, Hernández-Guerra, Manuel, González-Gay, Miguel Á., Ferraz-Amaro, Iván
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304915/ https://www.ncbi.nlm.nih.gov/pubmed/34300227 http://dx.doi.org/10.3390/jcm10143062

Ejemplares similares

Carotid Plaque Assessment Reclassifies Patients with Inflammatory Bowel Disease into Very-High Cardiovascular Risk
por: Hernández-Camba, Alejandro, et al.
Publicado: (2021)

QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease
por: Carrillo-Palau, Marta, et al.
Publicado: (2021)

Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease
por: Hernández-Camba, Alejandro, et al.
Publicado: (2022)

Serum Levels of Lipoprotein Lipase Are Increased in Patients with Inflammatory Bowel Disease
por: Rodríguez-Hernández, Orvelindo, et al.
Publicado: (2023)

COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire
por: Ramos, Laura, et al.
Publicado: (2023)

COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire
por: Ramos, Laura, et al.
Publicado: (2023)

Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection
por: Hernández Camba, Alejandro, et al.
Publicado: (2022)

Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection
por: Hernández Camba, Alejandro, et al.
Publicado: (2022)

An Enhanced High-Volume Preparation for Colonoscopy Is Not Better Than a Conventional Low-Volume One in Patients at Risk of Poor Bowel Cleansing: A Randomized Controlled Trial
por: Gimeno-García, Antonio Z., et al.
Publicado: (2021)

Diet and microbiome in the beginning of the sequence of gut inflammation
por: Ceballos, Daniel, et al.
Publicado: (2021)

Artificial Intelligence Applied to Colonoscopy: Is It Time to Take a Step Forward?
por: Gimeno-García, Antonio Z., et al.
Publicado: (2023)

SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project
por: Ferreiro-Iglesias, Rocío, et al.
Publicado: (2022)

SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project
por: Ferreiro-Iglesias, Rocío, et al.
Publicado: (2022)

Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
por: Almeida-Santiago, Cristina, et al.
Publicado: (2022)

Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis
por: Almeida-Santiago, Cristina, et al.
Publicado: (2022)

Appropriateness of high-priority criteria and safety of endoscopy procedures during the COVID-19 lockdown
por: Morales-Arraez, Dalia, et al.
Publicado: (2022)

Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus
por: Quevedo-Abeledo, Juan Carlos, et al.
Publicado: (2022)

Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines
por: Hernández, Vicent, et al.
Publicado: (2012)

Infliximab concentrations in two non-switching cohorts of patients with inflammatory bowel disease: originator vs. biosimilar
por: Martínez-Feito, Ana, et al.
Publicado: (2020)

Inflammatory Bowel Disease Infusion Therapy Adherence in a Rural Pediatric Population
por: Hernandez Garcia, Laura R, et al.
Publicado: (2023)

Public Awareness of Colorectal Cancer Screening: Knowledge, Attitudes, and Interventions for Increasing Screening Uptake
por: Gimeno Garcia, Antonio Z., et al.
Publicado: (2014)

Seroprevalence of ANTI-SARS-CoV-2 antibodies in patients with inflammatory bowel disease
por: Martin-Arranz, M. D., et al.
Publicado: (2023)

Role of bioactive fatty acids in nonalcoholic fatty liver disease
por: Juárez-Hernández, Eva, et al.
Publicado: (2016)

Colon Bowel Preparation in the Era of Artificial Intelligence: Is There Potential for Enhancing Colon Bowel Cleansing?
por: Gimeno-García, Antonio Z, et al.
Publicado: (2023)

The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
por: de Armas-Rillo, Laura, et al.
Publicado: (2022)

The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease
por: Hernandez Roman, Jose, et al.
Publicado: (2020)

Contribution of Cyclooxygenase End Products and Oxidative Stress to Intrahepatic Endothelial Dysfunction in Early Non-Alcoholic Fatty Liver Disease
por: Gonzalez-Paredes, Francisco Javier, et al.
Publicado: (2016)

Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases
por: Hernández-Ceballos, Winston, et al.
Publicado: (2021)

Mechanical forces as information: an integrated approach to plant and animal development
por: Hernández-Hernández, Valeria, et al.
Publicado: (2014)

Students’ views on the use of extensive reading in an efl advanced level at a university: /
por: Hernández Carrillo, Leidy Laura
Publicado: (2016)

Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention
por: Aleksandrova, Krasimira, et al.
Publicado: (2017)

Low–Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease
por: Zuarth-Vázquez, Julia, et al.
Publicado: (2023)

Growth and Puberty in Children with Inflammatory Bowel Diseases
por: Amaro, Flavia, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history
por: Magrì, Salvatore, et al.
Publicado: (2019)

Prevalencia de helmintiasis gastrointestinales en monos araña (Ateles geoffroyi) del parque zoológico botánico Miguel Ángel de Quevedo en Veracruz, Veracruz, México /
por: González Hernández, Milagros
Publicado: (2004)

HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study
por: Chaparro, María, et al.
Publicado: (2021)

Relevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver Disease
por: Hernandez-Rodas, Maria Catalina, et al.
Publicado: (2015)

Explainable AI toward understanding the performance of the top three TADPOLE Challenge methods in the forecast of Alzheimer’s disease diagnosis
por: Hernandez, Monica, et al.
Publicado: (2022)

Efectos de la contaminación en las líneas de transmisión aéreas"/
por: Vela Hernández, Pablo
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_fhlbh6j4lk1s2g33ba1da25rdh